Quality and Patient Safety Articles
  • EMG/NCS and Risk of Bleeding
  • Needle EMG and the Risk of Pneumothorax
  • NM Complications of Immune Checkpoint Inhibitors
  • Percutaneous Sharp Injuries: Primary Prevention
  • Safety of Direct Oral Anticoagulants (DOACS) in Needle EMG
  • Statins and Immune-Mediated Necrotizing Myopathy
Description
The AANEM Quality and Patient Safety Committee develops articles to be published in the Spark that focus on patient safety issues particular to neuromuscular and electrodiagnostic physicians. This collection of previously published short articles provides answers to questions in a multiple choice format with explanation and sources.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
Contains (16)
Percutaneous Sharp Injuries – Post-exposure Procedures
EMG/NCS and Risk of Bleeding
Needle EMG and the Risk of Pneumothorax
NM Complications of Immune Checkpoint Inhibitors
Percutaneous Sharp Injuries: Primary Prevention
Safety of Direct Oral Anticoagulants (DOACS) in Needle EMG
Statins and Immune-Mediated Necrotizing Myopathy
Colchicine Toxicity
Complement inhibitors in treatment of myasthenia gravis
Electrodiagnostic Findings After Chemodenervation
HIPAA Compliance During EDX Documentation
Immune Checkpoint Inhibitors Related Neuromuscular Adverse Effects
Impact of Antibiotics in Patients With Myasthenia Gravis
Importance of Temperature in Nerve Conduction Studies
Mononeuropathies in Scapular Winging
Toxic Neuropathy Following Treatment With Linezolid
Recommended
 

2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

           
© 2025 AANEM. All rights reserved. Content may not be reproduced or used in AI systems without AANEM's written permission. 
Powered By